New York Firm Raises $48 Million To Develop New Cancer Immunotherapies – Forbes

Forbes
… at Weill Cornell Medical by Laurie Glimcher, who was previously dean there and is now chief executive of the Dana-Farber Cancer Institute in Boston, and Juan Cubillos-Ruiz, an assistant professors of microbiology and immunonology. In Quentis

and more

…read more

Source:: New York City News By Google News

About the Author

Zennie Abraham
Zennie Abraham | Zennie Abraham or "Zennie62" is the founder of Zennie62Media which consists of zennie62blog.com and a multimedia blog news aggregator and video network, and 78-blog network, with social media and content development services and consulting. Zennie is a pioneer video blogger, YouTube Partner, social media practitioner, game developer, and pundit. Note: news aggregator content does not reflect the personal views of Mr. Abraham.

Be the first to comment on "New York Firm Raises $48 Million To Develop New Cancer Immunotherapies – Forbes"

Leave a comment

Your email address will not be published.




Open

Maria Ayerdi Kaplan

Close